You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 167 No. 2, January 22, 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Investigation
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (39)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in this journal
 Topic Collections
 •Aging/ Geriatrics
 •Psychiatry
 •Depression
 •Osteoporosis
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Effect of Selective Serotonin Reuptake Inhibitors on the Risk of Fracture

J. Brent Richards, MD; Alexandra Papaioannou, MD, MSc; Jonathan D. Adachi, MD; Lawrence Joseph, PhD; Heather E. Whitson, MD; Jerilynn C. Prior, MD; David Goltzman, MD; for the Canadian Multicentre Osteoporosis Study (CaMos) Research Group

Arch Intern Med. 2007;167(2):188-194.

Background  Depression and osteoporotic fractures are common ailments among elderly persons. Selective serotonin reuptake inhibitors (SSRIs) are frequently used in the treatment of depression in this population, and the association between daily SSRI use and fragility fractures is unclear. Our objective was to examine the effect of daily SSRI use on the risk of incident clinical fragility fracture.

Methods  A population-based, randomly selected, prospective cohort study of 5008 community-dwelling adults 50 years and older, followed up over 5 years for incident fractures. Clinical fragility fractures were classified as minimal trauma fractures that were clinically reported and radiographically confirmed. The risk of fragility fracture associated with daily SSRI use was determined while controlling for relevant covariates.

Results  Daily SSRI use was reported by 137 subjects. After adjustment for many potential covariates, daily SSRI use was associated with substantially increased risk of incident clinical fragility fracture (hazard rate, 2.1; 95% confidence interval, 1.3-3.4). Daily SSRI use was also associated with increased odds of falling (odds ratio, 2.2; 95% confidence interval, 1.4-3.5), lower bone mineral density at the hip, and a trend toward lower bone mineral density at the spine. These effects were dose dependent and were similar for those who reported taking SSRIs at baseline and at 5 years' follow-up.

Conclusions  Daily SSRI use in adults 50 years and older remained associated with a 2-fold increased risk of clinical fragility fracture after adjustment for potential covariates. Depression and fragility fractures are common in this age group, and the elevated risk attributed to daily SSRI use may have important public health consequences.


Author Affiliations: Division of Endocrinology and Metabolism, Department of Medicine (Drs Richards and Goltzman), and Department of Epidemiology and Biostatistics (Drs Richards and Joseph), McGill University, and Bone and Calcium Research Laboratories, Royal Victoria Hospital (Dr Goltzman), Montreal, Quebec; Division of Geriatric Medicine, Department of Medicine, Hamilton Health Sciences (Dr Papaioannou), and Department of Medicine, St Joseph's Healthcare (Dr Adachi), McMaster University, Hamilton, Ontario; Department of Endocrinology and Medicine, University of British Columbia, Vancouver (Dr Prior); Division of Geriatrics, Department of Medicine, Duke University School of Medicine, Durham, NC (Dr Whitson).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED LETTERS

Selective Serotonin Reuptake Inhibitors and Risk of Fracture in Elderly Persons
Oladipo Kukoyi
Arch Intern Med. 2007;167(21):2369.
EXTRACT | FULL TEXT  

Association Between SSRI Use and Fractures and the Effect of Confounding by Indication
Gijsbertus Ziere, Jeanne P. Dieleman, Tischa J. M. van der Cammen, and Bruno H. Ch. Stricker
Arch Intern Med. 2007;167(21):2369-2370.
EXTRACT | FULL TEXT  

A Possible Role of Recurrent Major Depression in Risk of Fracture
Sinead M. O’Brien
Arch Intern Med. 2007;167(21):2370.
EXTRACT | FULL TEXT  

A Possible Role of Recurrent Major Depression in Risk of Fracture—Reply
J. Brent Richards, Alexandra Papaioannou, Jonathan D. Adachi, Lawrence Joseph, Heather E. Whitson, Jerilynn C. Prior, David Goltzman, and for the CaMos Research Group
Arch Intern Med. 2007;167(21):2370-2371.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Review: Problems associated with long-term treatment with selective serotonin reuptake inhibitors
Moret et al.
J Psychopharmacol 2009;23:967-974.
ABSTRACT  

How effective are physical activity interventions for alleviating depressive symptoms in older people? A systematic review
Blake et al.
Clin Rehabil 2009;23:873-887.
ABSTRACT  

Psychiatric symptoms of dementia: Treatable, but no silver bullet
SCHWAB et al.
Cleveland Clinic Journal of Medicine 2009;76:167-174.
ABSTRACT | FULL TEXT  

Escitalopram for Older Adults With Generalized Anxiety Disorder: A Randomized Controlled Trial
Lenze et al.
JAMA 2009;301:295-303.
ABSTRACT | FULL TEXT  

Risk of Fractures with Selective Serotonin-Reuptake Inhibitors or Tricyclic Antidepressants
Ginzburg and Rosero
The Annals of Pharmacotherapy 2009;43:98-103.
ABSTRACT | FULL TEXT  

Depression, Antidepressants, and Bone Mineral Density in a Population-Based Cohort
Mezuk et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2008;63:1410-1415.
ABSTRACT | FULL TEXT  

Association of Depressive Symptoms and Anxiety With Bone Mass and Density in Ever-Smoking and Never-Smoking Adolescent Girls
Dorn et al.
Arch Pediatr Adolesc Med 2008;162:1181-1188.
ABSTRACT | FULL TEXT  

Use of proton pump inhibitors and risk of osteoporosis-related fractures
Targownik et al.
CMAJ 2008;179:319-326.
ABSTRACT | FULL TEXT  

Low Bone Mass in Premenopausal Women With Depression
Eskandari et al.
Arch Intern Med 2007;167:2329-2336.
ABSTRACT | FULL TEXT  

Selective Serotonin Reuptake Inhibitors and Risk of Fracture in Elderly Persons
Kukoyi
Arch Intern Med 2007;167:2369-2369.
FULL TEXT  

A Possible Role of Recurrent Major Depression in Risk of Fracture
O'Brien
Arch Intern Med 2007;167:2370-2370.
FULL TEXT  

Association Between SSRI Use and Fractures and the Effect of Confounding by Indication
Ziere et al.
Arch Intern Med 2007;167:2369-2370.
FULL TEXT  

A Possible Role of Recurrent Major Depression in Risk of Fracture Reply
Richards et al.
Arch Intern Med 2007;167:2370-2371.
FULL TEXT  

Mend the Mind, but Mind the Bones!: Balancing Benefits and Potential Skeletal Risks of Serotonin Reuptake Inhibitors
Saag
Arch Intern Med 2007;167:1231-1232.
FULL TEXT  

Patient Assessment in the Diagnosis, Prevention, and Treatment of Osteoporosis
Lata and Elliott
Nutr Clin Pract 2007;22:261-275.
ABSTRACT | FULL TEXT  

SSRIs Increase Fracture Risk in Older Women
JWatch Women's Health 2007;2007:1-1.
FULL TEXT  

SSRIs and Medical Illness: The Good and the Bad
JWatch Psychiatry 2007;2007:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.